Owners, management and financials
CVR: 36697016
DKK 1,811,082
Gross profit
Net result: DKK -4,776,853
Jonas Rosager Henriksen (5-9,99%), TLA-HOLDING 2010 ApS (10-14,99%)
2 more
CVR · view owners
Simon Skjøde Jensen
Board: Lone Schøtt Kunøe (chair) and 3 members
CVR · view management
Active
Founded 25 March 2015
CVR · view overview
1 employee
CVR · 2018
Director role ended: Thomas Lars Andresen
CVR · 01/07/2023
View the full event history
MonTa Biosciences ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Skjøde Jensen. The board consists of Lone Schøtt Kunøe (chair), Esper Boel, Sven Madsen and Søren Tulstrup. The company's owners include Jonas Rosager Henriksen, TLA-HOLDING 2010 ApS and JENSEN BIOCONSULT ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,811,082 and a net result of DKK -4,776,853 compared with DKK -3,920,572 the year before. Equity in the 2025 report amounted to DKK -10,304,549.
Source: annual report 2025, Danish Business Authority
MonTa Biosciences ApS is currently facing significant financial challenges, as evidenced by its declining equity and consistent losses over the past few years. Gross profit has fluctuated, peaking at 2,130,489 DKK in 2021 but dropping to 1,811,082 DKK in 2025, while losses have increased from -1,439,137 DKK in 2022 to -4,776,853 DKK in 2025. The company's equity has deteriorated sharply, moving from 3,110,639 DKK in 2021 to -10,304,549 DKK in 2025, raising concerns about its financial stability. Despite its position in the research and experimental development sector, the lack of disclosed revenue and mounting losses suggest a precarious trajectory that may hinder its growth prospects.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at drive forretning med udvikling og handel af målrettet lipidbaseret leveringsteknologi samt behandlinger af kræft, herunder projektet vedrørende udvikling af en stærk datapakke for TLR7 agonist 1V270 lipid formulering og dens immunoterapeutiske aktivitet til behandling af kræft med henblik på at opnå væsentlig kommerciel værdiskabelse og andre relaterede aktiviteter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.8 mio. | -4.8 mio. | 103.7 mio. | -10.3 mio. | 3 | |
| 202401/01/2024 – 31/12/2024 | 1.5 mio. | -3.9 mio. | 83.4 mio. | -5.5 mio. | 3 | |
| 202301/01/2023 – 31/12/2023 | 2 mio. | -3.3 mio. | 73.4 mio. | -1.6 mio. | 4 | |
| 202201/01/2022 – 31/12/2022 | 1.8 mio. | -1.4 mio. | 49.2 mio. | 1.7 mio. | 3 | |
| 202101/01/2021 – 31/12/2021 | 2.1 mio. | 1.4 mio. | 35 mio. | 3.1 mio. | 3 | |
| 202001/01/2020 – 31/12/2020 | -13.3 mio. | -13.3 mio. | 20.4 mio. | 1.7 mio. | 4 | |
| 201901/01/2019 – 31/12/2019 | -7.1 mio. | -8.6 mio. | 15.4 mio. | 15 mio. | 3 | |
| 201801/01/2018 – 31/12/2018 | -178 t. | -760 t. | 723 t. | 686 t. | 1 | |
| 201701/01/2017 – 31/12/2017 | -25 t. | -654 t. | 1.5 mio. | 1.4 mio. | 1 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of MonTa Biosciences ApS is 36697016.
The owners of MonTa Biosciences ApS include Jonas Rosager Henriksen, TLA-HOLDING 2010 ApS and JENSEN BIOCONSULT ApS.
The management of MonTa Biosciences ApS consists of Simon Skjøde Jensen.
The board of MonTa Biosciences ApS consists of Lone Schøtt Kunøe, Esper Boel and Sven Madsen, with Lone Schøtt Kunøe as chair.
In 2025, MonTa Biosciences ApS reported a gross profit of DKK 1,811,082.
MonTa Biosciences ApS had 1 employee in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
MonTa Biosciences ApS has published its annual report for 2025. Gross profit came to DKK 1,811,082, and the net result was DKK -4,776,853.
As of June 30, 2025, Søren Tulstrup has joined the board of directors of MonTa Biosciences ApS.
As of June 23, 2025, Peter Birk Rasmussen has left the board of directors of MonTa Biosciences ApS.
MonTa Biosciences ApS has published its annual report for 2024. Gross profit came to DKK 1,479,565, and the net result was DKK -3,920,572.
MonTa Biosciences ApS has published its annual report for 2023. Gross profit came to DKK 2,024,634, and the net result was DKK -3,278,626.
As of July 1, 2023, Thomas Lars Andresen has stepped down as director of MonTa Biosciences ApS.
MonTa Biosciences ApS has published its annual report for 2022. Gross profit came to DKK 1,756,938, and the net result was DKK -1,439,137.
As of March 28, 2023, Lone Schøtt Kunøe has joined the board of directors of MonTa Biosciences ApS.
As of March 28, 2023, Peter Birk Rasmussen has joined the board of directors of MonTa Biosciences ApS.
As of March 27, 2023, Lone Schøtt Kunøe has left the board of directors of MonTa Biosciences ApS.
As of March 27, 2023, Peter Birk Rasmussen has left the board of directors of MonTa Biosciences ApS.
As of December 29, 2022, TLA-HOLDING 2010 ApS is registered as an owner of MonTa Biosciences ApS with an ownership share of 10%.
As of December 29, 2022, JENSEN BIOCONSULT ApS is registered as an owner of MonTa Biosciences ApS with an ownership share of 15%.
As of December 29, 2022, Consolidated Biosciences ApS is registered as an owner of MonTa Biosciences ApS with an ownership share of 50%.
MonTa Biosciences ApS has published its annual report for 2021. Gross profit came to DKK 2,130,489, and the net result was DKK 1,406,263.
MonTa Biosciences ApS has published its annual report for 2020. Gross profit came to DKK -13,309,779, and the net result was DKK -13,292,779.
MonTa Biosciences ApS has published its annual report for 2019. Gross profit came to DKK -7,101,320, and the net result was DKK -8,588,772.
MonTa Biosciences ApS has published its annual report for 2018. Gross profit came to DKK -177,969, and the net result was DKK -759,993.
As of January 22, 2019, Sven Madsen has joined the board of directors of MonTa Biosciences ApS.
As of January 22, 2019, Lone Schøtt Kunøe has joined the board of directors of MonTa Biosciences ApS.
As of January 22, 2019, Thomas Lars Andresen has left the board of directors of MonTa Biosciences ApS.
As of January 22, 2019, Jonas Rosager Henriksen is registered as an owner of MonTa Biosciences ApS with an ownership share of 5%.
MonTa Biosciences ApS has published its annual report for 2017. Gross profit came to DKK -24,932, and the net result was DKK -653,993.
MonTa Biosciences ApS has published its interim report for the period July 1, 2016 – December 31, 2016.
As of February 22, 2017, Thomas Lars Andresen has joined the board of directors of MonTa Biosciences ApS.
As of February 22, 2017, Esper Boel has joined the board of directors of MonTa Biosciences ApS.
As of February 22, 2017, Peter Birk Rasmussen has joined the board of directors of MonTa Biosciences ApS.
MonTa Biosciences ApS has published its interim report for the period March 26, 2015 – June 30, 2016.
As of July 5, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of MonTa Biosciences ApS.
As of March 26, 2015, Thomas Lars Andresen is registered as director of MonTa Biosciences ApS.
As of March 26, 2015, Simon Skjøde Jensen is registered as adm. dir. of MonTa Biosciences ApS.
MonTa Biosciences ApS was founded on March 25, 2015.
Companies in the same industry and area
CVR 37300233
CVR 57821159
CVR 15994142
CVR 46551184
CVR 37109886
